Transplantation, AutologousTransplantation, HomologousHematopoietic Stem Cell TransplantationStem Cell TransplantationTransplantation ConditioningStem CellsGraft vs Host DiseaseBone Marrow TransplantationHematologic NeoplasmsPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsMultiple MyelomaTreatment OutcomeLiver TransplantationGraft SurvivalTransplantation ChimeraRecurrenceHematopoietic Stem Cell MobilizationRemission InductionBusulfanGraft vs Tumor EffectCombined Modality TherapyMelphalanSalvage TherapyTissue DonorsMyeloablative AgonistsGraft vs Leukemia EffectWhole-Body IrradiationAntigens, CD34Retrospective StudiesKidney TransplantationImmunosuppressive AgentsSurvival AnalysisEmbryonic Stem CellsDisease-Free SurvivalVidarabineCyclophosphamideLeukemiaLeukemia, Myeloid, AcuteAntineoplastic Combined Chemotherapy ProtocolsLymphoma, Non-HodgkinCell TransplantationHistocompatibility TestingTime FactorsSurvival RateGranulocyte Colony-Stimulating FactorAdult Stem CellsNeoplasm, ResidualMyelodysplastic SyndromesCytomegalovirus InfectionsHeart TransplantationLymphocyte TransfusionCell DifferentiationFollow-Up StudiesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveBone Marrow PurgingTransplantation ImmunologyHodgkin DiseaseCytarabinePluripotent Stem CellsLeukapheresisLymphocyte DepletionCells, CulturedMesenchymal Stem Cell TransplantationLung TransplantationGraft RejectionT-LymphocytesCord Blood Stem Cell TransplantationCarmustineBone Marrow CellsMinor Histocompatibility AntigensEtoposideSiblingsPrognosisBone MarrowAntilymphocyte SerumHistocompatibilityVirus ActivationPrecursor Cell Lymphoblastic Leukemia-LymphomaCell SeparationStem Cell NicheNeural Stem CellsFlow CytometryBlood Transfusion, AutologousInduced Pluripotent Stem CellsCytomegalovirusImmunosuppressionAntineoplastic AgentsAcute DiseaseChimerismMesenchymal Stromal CellsAnemia, AplasticOrgan TransplantationTransplantation, IsogeneicThalidomideHematopoiesisMultipotent Stem CellsAntibodies, MonoclonalAntigens, CDIslets of Langerhans Transplantation